1620579-34-1 Usage
Description
(S)-7-chloro-2-methyl-2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one is a complex and specific chemical compound belonging to the class of imidazopyrimidine derivatives. It is characterized by its stereospecific configuration, denoted by the "(S)" prefix, and features a chlorine atom and a methyl group within its heterocyclic ring structure composed of nitrogen and carbon atoms. This unique structure and properties suggest potential applications in pharmaceutical and medicinal chemistry, warranting further research and exploration for the development of novel drugs or therapeutic agents.
Uses
Used in Pharmaceutical Industry:
(S)-7-chloro-2-methyl-2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one is used as a chemical compound for its potential application in the development of novel drugs or therapeutic agents. Its unique structure and properties make it a promising candidate for further research and exploration in medicinal chemistry.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (S)-7-chloro-2-methyl-2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one is used as a subject of study for understanding its potential interactions with biological targets and its possible role in the treatment of various diseases. (S)-7-chloro-2-methyl-2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one's specific structure may offer insights into new mechanisms of action or novel drug design strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 1620579-34-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,2,0,5,7 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1620579-34:
(9*1)+(8*6)+(7*2)+(6*0)+(5*5)+(4*7)+(3*9)+(2*3)+(1*4)=161
161 % 10 = 1
So 1620579-34-1 is a valid CAS Registry Number.
1620579-34-1Relevant articles and documents
1,2,3,5-TETRAHYDROIMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES AND DISORDERS MEDIATED BY LP-PLA2
-
Page/Page column 24; 25, (2016/02/18)
The present invention relates to novel compounds that inhibit Lp‐PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases or disorders associated with the activity of Lp‐PLAs
COMPOUNDS
-
Paragraph 0188; 0189; 0190, (2014/08/07)
The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
